Rating
Buy
Price target
$780
Previous
$805
Implied upside
+17%

Stifel analyst Mark Kelley lowered the price target on Meta (NASDAQ: META) to $780.00 (from $805.00) while maintaining a Buy rating.

“Solid revenue and GAAP EPS results came in ahead of expectations, even scrubbing out one time benefits for the latter.

DAPs declined sequentially (first time since 2Q19), though would have grown excluding access headwinds in Iran & Russia.

2Q guidance bracketed consensus, and totex for ’26 was unchanged, though FY26 capex guidance was revised higher (+$10bn), again sparking questions around ROI.

Mgmt continues to highlight its grand picture of the future via Superintelligence, though we believe having a publicly announced model out of MSL is a good start for helping investors wrap their heads around where dollars pay off long-term (Muse driving +DD% Meta AI sessions / user).

In the meantime, the debate centers on the positives from an accelerating core business vs. a very real FCF drain (we now model neg.

FCF in ’26). We update our ests, and our TP goes to $780 as a result.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.